Analysis Of Income And Expense [Abstract]

Affluent Medical - Filing #2813471

Concept 2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue
- EUR
- EUR
Material income and expense [abstract]
Finance income (cost)
Other finance income (cost)
29,000 EUR
4,000 EUR
Gains (losses) on change in fair value of derivatives [abstract]
Gains (losses) on change in fair value of derivatives
60,000 EUR
1 041 EUR
Expenses by nature [abstract]
Raw materials and consumables used
2 443 EUR
2 518 EUR
Classes of employee benefits expense [abstract]
Employee benefits expense
5 213 EUR
4 405 EUR
Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract]
Depreciation and amortisation expense [abstract]
Depreciation and amortisation expense
2 450 EUR
2 420 EUR
Impairment loss (reversal of impairment loss) recognised in profit or loss
119,000 EUR
98,000 EUR
Tax expense other than income tax expense
85,000 EUR
88,000 EUR
Other expenses, by nature
5 566 EUR
5 496 EUR
Disclosure of attribution of expenses by nature to their function [text block]
Disclosure of attribution of expenses by nature to their function [abstract]
Disclosure of attribution of expenses by nature to their function [line items]
Miscellaneous other comprehensive income [abstract]
Other comprehensive income, before tax, exchange differences on translation of foreign operations and hedges of net investments in foreign operations [abstract]
Other comprehensive income, before tax, exchange differences on translation of foreign operations
- EUR
1,000 EUR
Share of profit (loss) of associates and joint ventures accounted for using equity method [abstract]
Share of profit (loss) of associates and joint ventures accounted for using equity method
- EUR
14,000 EUR
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income
- EUR
15 215 EUR
15 215 EUR
- EUR
12,000 EUR
- EUR
15 227 EUR
- EUR
- EUR
14 820 EUR
32,000 EUR
- EUR
- EUR
1,000 EUR
14 787 EUR
14 787 EUR
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent
15 215 EUR
14 787 EUR
Comprehensive income attributable to non-controlling interests, continuing and discontinued operations [abstract]
Comprehensive income, attributable to non-controlling interests
- EUR
- EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.